These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15373325)

  • 21. Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.
    Gitelson E; Hammond C; Mena J; Lorenzo M; Buckstein R; Berinstein NL; Imrie K; Spaner DE
    Clin Cancer Res; 2003 May; 9(5):1656-65. PubMed ID: 12738718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Membrane characteristics of pathological clones of B-lymphocytes in patients with chronic lymphocytes leukemia (CLL)].
    Pluta A
    Pol Arch Med Wewn; 1989; 82(4-6):195-201. PubMed ID: 2642224
    [No Abstract]   [Full Text] [Related]  

  • 23. Restoration of high immunoglobulin gene expression in chronic lymphoid leukemia: a possible application for gene therapy.
    Tremisi PJ; Bich-Thuy L
    Cell Immunol; 1991 Jul; 135(2):326-34. PubMed ID: 1903674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An update on current and prospective immunotherapies for chronic lymphocytic leukemia.
    Emole JN; Locke FL; Pinilla-Ibarz J
    Immunotherapy; 2015; 7(4):455-66. PubMed ID: 25917633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highlights from the XVIII International Workshop on Chronic Lymphocytic Leukemia.
    Clin Adv Hematol Oncol; 2019 Nov; 17 Suppl 16(11):1-28. PubMed ID: 33843853
    [No Abstract]   [Full Text] [Related]  

  • 26. Chronic lymphocytic leukemia.
    Chiorazzi N; Rai KR; Ferrarini M
    N Engl J Med; 2005 Feb; 352(8):804-15. PubMed ID: 15728813
    [No Abstract]   [Full Text] [Related]  

  • 27. Perspectives in chronic lymphocytic leukemia biology and management.
    Dighiero G
    Hematol Oncol Clin North Am; 2004 Aug; 18(4):927-43, x. PubMed ID: 15325707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.
    Del Poeta G; Ilaria Del Principe M; Buccisano F; Maurillo L; Niscola P; Venditti A; Amadori S
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1787-800. PubMed ID: 17181492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher levels of reactive oxygen species are associated with anergy in chronic lymphocytic leukemia.
    Linley A; Valle-Argos B; Steele AJ; Stevenson FK; Forconi F; Packham G
    Haematologica; 2015 Jul; 100(7):e265-8. PubMed ID: 25749826
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-apoptosis function of TNF-alpha in chronic lymphocytic leukemia: lessons from Crohn's disease and the therapeutic potential of bupropion to lower TNF-alpha.
    Kast RE; Altschuler EL
    Arch Immunol Ther Exp (Warsz); 2005; 53(2):143-7. PubMed ID: 15928583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in therapy of chronic lymphocytic leukaemia.
    Routledge DJ; Bloor AJ
    Br J Haematol; 2016 Aug; 174(3):351-67. PubMed ID: 27291144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of ROR1 Protein Expression in Mice with Reconstituted Human Immune System Components.
    Leung CS
    J Immunol Res; 2018; 2018():2480931. PubMed ID: 29850623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients.
    Mimmi S; Vecchio E; Iaccino E; Rossi M; Lupia A; Albano F; Chiurazzi F; Fiume G; Pisano A; Ceglia S; Pontoriero M; Golino G; Tassone P; Quinto I; Scala G; Palmieri C
    Leukemia; 2016 Dec; 30(12):2419-2422. PubMed ID: 27568521
    [No Abstract]   [Full Text] [Related]  

  • 34. Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells.
    Efremov DG; Gobessi S; Longo PG
    Autoimmun Rev; 2007 Dec; 7(2):102-8. PubMed ID: 18035318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-chronic lymphocytic leukemia: a malignancy of anti-self B cells.
    Caligaris-Cappio F
    Blood; 1996 Apr; 87(7):2615-20. PubMed ID: 8639876
    [No Abstract]   [Full Text] [Related]  

  • 36. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
    Mulligan CS; Thomas ME; Mulligan SP
    N Engl J Med; 2008 Nov; 359(19):2065-6; author reply 2066. PubMed ID: 18987375
    [No Abstract]   [Full Text] [Related]  

  • 37. Novel agents in chronic lymphocytic leukemia.
    Lamanna N; O'Brien S
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):137-145. PubMed ID: 27913472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A polyvalent cellular vaccine induces T-cell responses against specific self-antigens overexpressed in chronic lymphocytic B-cell leukemia.
    Kronenberger K; Nössner E; Frankenberger B; Wahl U; Dreyling M; Hallek M; Mocikat R
    J Immunother; 2008 Oct; 31(8):723-30. PubMed ID: 18779747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytoplasmic immunoglobulins in chronic B-lymphoid leukemia].
    Filippi JF; Nicolino-Brunet C; Tubiana N; Carcassonne Y; Sampol J
    Pathol Biol (Paris); 1991 Jan; 39(1):47-9. PubMed ID: 2011410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunosuppressor activity of B-cells in patients with chronic lymphocytic leukemia. Their possible role in the pathogenesis of the disease].
    Chernykh ER; Tikhonova MA; Ostanin AA; Shevela EIa; Blazhievich IA; Shubinskiĭ GZ
    Vestn Akad Med Nauk SSSR; 1991; (12):39-43. PubMed ID: 1801472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.